MB12066

· Yungjin Pharm. Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MB12066, covering 2018-06-27 to 2018-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers [Phase 1]